These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18354876)

  • 1. Mitoxantrone: multiple sclerosis: too many serious adverse effects.
    Prescrire Int; 2008 Feb; 17(93):17. PubMed ID: 18354876
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
    Neuhaus O; Kieseier BC; Hartung HP
    Expert Rev Neurother; 2004 Jan; 4(1):17-26. PubMed ID: 15853611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic role of mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Pharmacol Ther; 2006 Jan; 109(1-2):198-209. PubMed ID: 16095713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy and multiple sclerosis: The devil is in the details.
    Bourdette D; Whitham R
    Neurology; 2010 May; 74(18):1410-1. PubMed ID: 20439842
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukaemia due to mitoxantrone.
    Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy of multiple sclerosis: mitoxantrone].
    Spuler S; Hohlfeld R
    Nervenarzt; 1994 Feb; 65(2):136-8. PubMed ID: 8164768
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mitoxantrone for the treatment of patients with multiple sclerosis].
    Komori M; Kondo T; Tanaka M
    Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone-induced extravasation.
    Luke E
    Oncol Nurs Forum; 2005 Jan; 32(1):27-9. PubMed ID: 15682531
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressants and multiple sclerosis].
    Ruiz-Peña JL; Izquierdo-Ayuso G
    Rev Neurol; 2002 Aug 16-31; 35(4):373-80. PubMed ID: 12235571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mitoxantrone, a new reality].
    Ruiz-Peña JL; Izquierdo G
    Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitoxantrone for multiple sclerosis in clinical practice.
    Rizvi SA; Zwibel H; Fox EJ
    Neurology; 2004 Dec; 63(12 Suppl 6):S25-7. PubMed ID: 15623666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
    Sumrall A; Dreiling B
    J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
    Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
    Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mitoxanthrone in the therapy of multiple sclerosis].
    Kieseier BC; Gold R; Hartung HP
    Nervenarzt; 2003 Oct; 74(10):906-10. PubMed ID: 14551698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone immunotherapy in multiple sclerosis.
    Gonsette RE
    Mult Scler; 1996 Jul; 1(6):329-32. PubMed ID: 9345411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Goodin DS; Arnason BG; Coyle PK; Frohman EM; Paty DW;
    Neurology; 2003 Nov; 61(10):1332-8. PubMed ID: 14638950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia.
    Cartwright MS; Jeffery DR; Lewis ZT; Koty PP; Stewart WT; Molnár I
    Neurology; 2007 May; 68(19):1630-1. PubMed ID: 17485652
    [No Abstract]   [Full Text] [Related]  

  • 19. Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
    Pandit L
    Neurol India; 2009; 57(4):424-5. PubMed ID: 19827224
    [No Abstract]   [Full Text] [Related]  

  • 20. Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
    Brandes DW
    Neurol India; 2009; 57(4):423-4. PubMed ID: 19827223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.